Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness of Nigella Sativa in the Treatment of SARS COV2 (COVID-19)

NCT04914767 is registered in ClinicalTrials.gov with Hôpital Universitaire Sahloul as lead sponsor.

NCT NCT04914767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04914767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness of Nigella Sativa in the Treatment of SARS COV2 (COVID-19)
Lead sponsor
Hôpital Universitaire Sahloul
Phase
Phase 1
Overall status
Completed
Start date
March 1, 2021
Completion date
December 31, 2021
Enrollment
500 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov2 infection